v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Underwritten Public Offering
Common Stock
Common Stock
Underwritten Public Offering
Additional Paid-in Capital
Additional Paid-in Capital
Underwritten Public Offering
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance at Dec. 31, 2024 $ 71,525   $ 2   $ 677,859   $ (602,305) $ (4,031)
Balance, shares at Dec. 31, 2024     204,943,306          
Stock-based compensation 6,484       6,484      
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs   $ 215,652   $ 1   $ 215,651    
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs, shares       57,777,777        
Issuance of common stock upon exercise of pre-funded warrants, shares     9,607,145          
Issuance of common stock, upon vesting and settlement of restricted stock units, net (51)       (51)      
Issuance of common stock, upon vesting and settlement of restricted stock units, net, shares     249,818          
Issuance of common stock upon exercise of stock options, net 121       121      
Issuance of common stock upon exercise of stock options, net ,shares     93,688          
Issuance of common stock under ESPP 75       75      
Issuance of common stock under ESPP, shares     58,326          
Gain (loss) on instrument specific credit risk 3,332             3,332
Net loss (48,411)           (48,411)  
Balance at Jun. 30, 2025 248,727   $ 3   900,139   (650,716) (699)
Balance, shares at Jun. 30, 2025     272,730,060          
Balance at Mar. 31, 2025 55,059   $ 2   681,177   (623,834) (2,286)
Balance, shares at Mar. 31, 2025     205,054,570          
Stock-based compensation 3,190       3,190      
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs   215,652   $ 1   215,651    
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs, shares       57,777,777        
Issuance of common stock upon exercise of pre-funded warrants, shares     9,607,145          
Issuance of common stock, upon vesting and settlement of restricted stock units, net, shares     196,880          
Issuance of common stock upon exercise of stock options, net 121       121      
Issuance of common stock upon exercise of stock options, net ,shares     93,688          
Gain (loss) on instrument specific credit risk 1,587             1,587
Net loss (26,882)           (26,882)  
Balance at Jun. 30, 2025 248,727   $ 3   900,139   (650,716) (699)
Balance, shares at Jun. 30, 2025     272,730,060          
Balance at Dec. 31, 2025 $ 246,938   $ 3   958,427   (711,300) (192)
Balance, shares at Dec. 31, 2025 285,051,648   285,051,648          
Stock-based compensation $ 11,357       11,357      
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs   215,676       215,676    
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs, shares       37,500,001        
Issuance of common stock, upon vesting and settlement of restricted stock units, net, shares     2,004,332          
Issuance of common stock upon exercise of stock options, net 1,207       1,207      
Issuance of common stock upon exercise of stock options, net ,shares     667,881          
Issuance of common stock under ESPP 176       176      
Issuance of common stock under ESPP, shares     78,418          
Gain (loss) on instrument specific credit risk 961             961
Net loss (89,049)           (89,049)  
Balance at Jun. 30, 2026 $ 387,266   $ 3   1,186,843   (800,349) 769
Balance, shares at Jun. 30, 2026 325,302,280   325,302,280          
Balance at Mar. 31, 2026 $ 211,944   $ 3   964,666   (753,710) 985
Balance, shares at Mar. 31, 2026     287,276,885          
Stock-based compensation 5,810       5,810      
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs   $ 215,676       $ 215,676    
Issuance of common stock and pre-funded warrants, upon closing of underwritten public offering, net of underwriting discounts and commissions, and other offering costs, shares       37,500,001        
Issuance of common stock, upon vesting and settlement of restricted stock units, net, shares     226,492          
Issuance of common stock upon exercise of stock options, net 691       691      
Issuance of common stock upon exercise of stock options, net ,shares     298,902          
Gain (loss) on instrument specific credit risk (216)             (216)
Net loss (46,639)           (46,639)  
Balance at Jun. 30, 2026 $ 387,266   $ 3   $ 1,186,843   $ (800,349) $ 769
Balance, shares at Jun. 30, 2026 325,302,280   325,302,280